ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is one times the annual (Dec. 2024) net income data. The Revenue data used here is one times the annual (Dec. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba ROE % Related Terms
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba ROE % Chart
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba ROE % vs REITs Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Dec. 2024) net income data.
ROE % is displayed in the 30-year financial page.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) has a ROE % of 5.51% as of Dec. 2024. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba and its competitors. This is 28% below median its historical median of 7.65.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's ROE % too high?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's current ROE % of 5.51% is 28% below median its 10-year median of 7.65. The REITs industry median ROE % is 6.13. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's value of 5.51% is 10.1% below this industry median. Overall, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's ROE % compare to WELL and VTR?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's ROE % of 5.51% can be compared against companies in the REITs industry. The industry median ROE % is 6.13. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's value of 5.51% is 10.1% below this benchmark. While the company's 10-year median is 7.65 vs. the industry median of 6.13, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a REITs company?
The median ROE % among REITs companies is 6.13, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's current ROE % of 5.51% is 10.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba and its competitors. For the REITs industry, the median ROE % is 6.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's current ROE % is 5.51%, which is 28% below median its own 10-year median of 7.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba stock overvalued right now?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) has a current ROE % of 5.51%. The stock's GF Value™ is R$33.29, compared to a current price of R$96.01 — trading 188.4% above its estimated fair value. The current ROE % is 5.51%, which is 28% below median its 10-year median of 7.65 and 10.1% below the REITs industry median of 6.13. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11), the current ROE % is 5.51% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) Overvalued in 2026?
Based on GuruFocus' analysis, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba stock appears to be overvalued.
The current stock price of R$96.01 is trading 188.4% above its estimated GF Value™ of R$33.29.
Key valuation signals for BSP:HUSC11:
ROE %: 5.51% (28% below median its 10-year median of 7.65)
GF Value™: R$33.29 vs. price of R$96.01 (188.4% above fair value)
No single metric tells the full story. See the BSP:HUSC11 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:HUSC11 has been successfully added to your 